Richard Baker, CEO for Hudson's Bay, said that he is doubling his efforts for the Saks Inc bid.
Sectors
Israel's Bank Leumi to invest US$50 million in three Viola Group funds
Bank Leumi stated that it is in advanced talks to invest around US$50 million in Viola Group's Viola Capital, Viola Private Equity, and Carmel Ventures.
CPPIB to acquire 27.6% stake in Aliansce
CCPIB said that they are set to acquire a 27.6% stake in Aliansce Shopping Center SA. The Canada Pension Plan Investment Board announced that they have agreed to acquire a 27.
Alexander Forbes sees opportunity in Africa
Alexander Forbes stated in its latest annual report that it is mulling further expansion in African countries.
MVC Capital's board appoints Scott Schuenke as CFO
MVC Capital revealed that it had appointed Scott J. Schuenke as chief financial officer replacing Peter Seidenberg.
Latest News
Summer Street Capital revealed that it had appointed Amy Standing as the firm's chief financial officer as current CFO, Ron Fleissner, retires.
Plains All American Pipeline affiliate, Plains GP Holdings LP, said that they plain to raise US$1 billion through an initial public offering.
Pearl Capital Partners announced the launch of their new fund worth around KES2.2 billion with the primary purpose of investing into small East African agricultural based businesses.
Isagen Energia Productiva, the Andean nation's third-largest electricity generator, is set to raise funding from an initial public offering.
Khosla Ventures brings up energy software specialist Bidgely's total funding to US$8 million with latest investment.
INEOS Olefins & Polymers USA partners with KBR to build one of the largest high-density polyethylene (HDPE) plants in America.
Mizuho Global Alternative Investments expect assets to rise as Japanese pensions continue to demand funds.
Investment company Cousins Properties plan to sell 60 million shares of its common stock to finance its pending acquisitions.
Cancer metabolism specialist Agios Pharmaceuticals closes its initial public offering on Monday. Agios Pharmaceuticals Inc. announced the conclusion of its initial public offering (IPO) of 6,772,221 shares of the company's common stock at a final offering price of US$18 per share.
